12:00 AM
Apr 01, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BCX4161: Phase I started

BioCryst began a U.K. Phase I trial to evaluate oral BCX4161 in health volunteers. Last November, BioCryst said FDA placed a clinical hold on an IND...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >